focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: UK stocks drop to five-month low ahead of CPI data

Tue, 16th Jun 2015 08:19

UK stocks dropped into the red for a third straight day on Tuesday on the back of ongoing concerns about Greece, a sell-off in China and caution ahead of inflation data.The FTSE 100 was trading 0.55% lower at 6,673.49 early on, after hitting a three-month closing low of 6,710.52 on Monday.The index has not finished below the 6,700 level since 20 January when it settled at 6,620.10.An abrupt end to debt talks on Sunday night in Brussels between Greece and its lenders has rattled investors' nerves over recent days, as discussions collapsed after just 45 minutes on the back of disagreements over issues such as pension reforms and tax rates.Meanwhile, stocks in Shanghai plunged again on Tuesday due to weakness in the financial sector as regulators tightened margin lending regulations and investors showed concerns and a new barrage of IPOs."The FTSE has already touched a five-month low this Tuesday, however briefly; yet the arrival of tangible news in the form of the UK's latest inflation figures later in the morning could provide some respite for the continually Eurozone-led index," said Spreadex analyst Connor Campbell.UK consumer price index (CPI) data due out at 09:30 is expected to show that prices bounced back in May after turning negative for the first time on record the month before. The annual rate of change in the CPI, the main measure of UK inflation, is predicted to show a 0.1% increase last month, according to the majority of analysts, following a 0.1% fall in April.UK producer price and retail price indices will also be released on Tuesday, along with an influx of data abroad, including building permits and housing starts in the States, the ZEW business sentiment index in Germany and new car registrations in Europe.Defensives gainA reduction in risk appetite benefitted stocks in defensive sectors such as tobacco and pharmaceuticals. British American Tobacco, Imperial Tobacco, AstraZeneca and Glaxosmithkline were all edging higher in London.GSK was also up on rumours it could become the latest takeover target in the industry. According to the Daily Mail, market participants are speculating that the company may face an approach from Switzerland's Roche or US company Johnson & Johnson at about 1900p per share.Mining stocks were among the worst performers, with Rio Tinto, Randgold and Antofagasta all in negative territory.Leisure group Whitbread fell despite saying it had started the new financial year well, as strong growth at its Costa and Premier Inn brands made up for weakness in the restaurants division.Industrial equipment hire company Ashtead underwhelmed with a 33% rise in full-year pre-tax profit to £473.8m on strong US and UK markets.Market MoverstechMARK 3,135.99 -0.49%FTSE 100 6,673.49 -0.55%FTSE 250 17,605.59 -0.69%FTSE 100 - RisersBritish American Tobacco (BATS) 3,452.00p +1.19%National Grid (NG.) 854.00p +0.64%GlaxoSmithKline (GSK) 1,358.00p +0.52%Imperial Tobacco Group (IMT) 3,186.00p +0.35%AstraZeneca (AZN) 4,151.50p +0.06%Tesco (TSCO) 214.10p +0.05%FTSE 100 - FallersInternational Consolidated Airlines Group SA (CDI) (IAG) 494.60p -2.73%Royal Mail (RMG) 492.60p -2.46%CRH (CRH) 1,791.00p -2.13%TUI AG Reg Shs (DI) (TUI) 1,150.00p -1.79%Antofagasta (ANTO) 715.50p -1.72%G4S (GFS) 276.60p -1.67%Randgold Resources Ltd. (RRS) 4,556.00p -1.51%Rio Tinto (RIO) 2,764.50p -1.50%easyJet (EZJ) 1,527.00p -1.48%Glencore (GLEN) 274.15p -1.47%FTSE 250 - RisersLadbrokes (LAD) 120.20p +2.73%CLS Holdings (CLI) 1,958.00p +2.03%Daejan Holdings (DJAN) 5,775.00p +1.67%NMC Health (NMC) 788.50p +1.09%Pets at Home Group (PETS) 276.50p +1.02%Jimmy Choo (CHOO) 159.30p +0.82%Rank Group (RNK) 219.10p +0.78%Virgin Money Holdings (UK) (VM.) 448.90p +0.76%JD Sports Fashion (JD.) 673.50p +0.75%Aberforth Smaller Companies Trust (ASL) 1,170.00p +0.52%FTSE 250 - FallersFoxtons Group (FOXT) 247.10p -2.95%Crest Nicholson Holdings (CRST) 529.50p -2.75%Lonmin (LMI) 126.20p -2.70%Evraz (EVR) 146.00p -2.67%Vesuvius (VSVS) 391.70p -2.61%Kaz Minerals (KAZ) 237.90p -2.50%Thomas Cook Group (TCG) 136.30p -2.43%Ophir Energy (OPHR) 119.00p -2.38%Allied Minds (ALM) 549.50p -2.14%Fidelity China Special Situations (FCSS) 165.00p -2.08%
More News
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.